SPONSOR
Colorado Prevention Center
Total Trials
2
Recruiting
2
Phases
Phase 3
Conditions studied: Heart Failure
Colorado Prevention Center is a clinical research sponsor with 2 registered studies on ClinicalTrials.gov, of which 2 are actively recruiting participants. Research covers conditions including Heart Failure.
The trial portfolio spans Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Colorado Prevention Center
How many clinical trials has Colorado Prevention Center sponsored?
ClinicalMetric currently tracks 2 clinical trials sponsored by Colorado Prevention Center, of which 2 are actively recruiting participants. These trials cover conditions including Heart Failure. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Colorado Prevention Center research focus on?
Colorado Prevention Center clinical trials span Heart Failure. The research pipeline includes Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Colorado Prevention Center clinical trial?
To participate in a Colorado Prevention Center trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Colorado Prevention Center trials with current recruitment status updated daily.
Clinical Trials by Colorado Prevention Center
NCT06024746 Phase 3
Recruiting
A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients with Heart Failure (CONFIRMATION-HF)
Heart Failure
NCT06033950 Phase 3
Recruiting
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not Eligible for Treatment With Steroidal Mineralocorticoid Receptor Antagonists
Heart Failure
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology